Could the HCV Drug Sofosbuvir Be Cardiotoxic? Could the HCV Drug Sofosbuvir Be Cardiotoxic?

The FDA warning about a potential interaction between amiodarone and the new HCV drugs Sovaldi/Harvoni prompts Dr John Mandrola to wonder if the problem may lie with the antivirals. theheart.org on Medscape
Source: Medscape Cardiology Headlines - Category: Cardiology Tags: Cardiology Expert Column Source Type: news